Phenotypic Differences and Clinical Outcomes of South Asian Children With IBD: A Singapore–Malaysia Study From the Asian PIBD Registry Network
Journal of Gastroenterology and Hepatology · 2025
DOI: 10.1111/jgh.17020 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Gastroenterology and Hepatology, 2025. Verfasst von James Guoxian Huang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore. Hauptthemen laut MEDLINE: Inflammatory Bowel Diseases, South Asian People. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background and Aim Existing literature largely contrasts pediatric inflammatory bowel disease (PIBD) phenotypic differences and outcomes of South Asians (SAs) with Caucasians. No published comparative data exist between SAs and non‐SAs within Asia‐Pacific. We aim to validate these comparisons within Asia‐Pacific, comparing SAs (“Indian,” “Bangladeshi,” “Nepali,” “Pakistani,” “Sri Lankan (Sinhalese/Tamil),” and “Maldivian”) with their non‐SA (“Chinese,” “Malay,” “Eurasian”, or “Others”) counterparts in the multiethnic populations of Singapore and Malaysia.
Methods
Clinical data from three centers in Singapore and Malaysia were compared, at baseline, 1‐year (1YFU) and 5‐year (5YFU) post‐diagnosis, between SAs and non‐SAs.
Results
Baseline, 1YFU, and 5YFU data were analyzed in 366, 260 (71.0%), and 127 (34.7%) patients, respectively. Compared with non‐SAs, SAs were significantly older (10.2 vs. 9.1 years, p = 0.013), had less very early–onset disease (15.5% vs. 33.0%, p = 0.001), a shorter time from symptom onset to diagnosis (5.9 vs. 8.9 months, p = 0.024), less growth retardation (5.9% vs. 14.0%, p = 0.035), and less comorbid liver diseases (1.4% vs. 9.4%, p = 0.002). SAs with Crohn's disease had more symptomatic perianal disease (18.3% vs. 9.4%, p = 0.016) and less isolated ileal L1 disease (10.2% vs. 20.7%, p = 0.057). No significant differences in induction therapies, maintenance immunosuppression or remission rates at 1YFU were noted, but at 5YFU, SAs had significantly lower rates of clinical remission (SA = 68.3% vs. non‐SA = 84.9%, p = 0.036), steroid‐free remission (SA = 53.7% vs. non‐SA = 73.3%, p = 0.043), and mucosal healing (calprotectin < 300 ug/g, 0.0% vs. 80.0%, p = 0.048).
Conclusions
We report unique phenotypic differences in SA and non‐SA children with IBD. SAs had poorer long‐term clinical outcomes, although short‐term outcomes and therapy usage patterns were comparable.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Paediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
- Khoo Teck Puat-National University Children's Medical Institute, National University Health System, Singapore, Singapore.
- Faculty of Medicine, University Malaya, Kuala Lumpur, Malaysia.
- Gastroenterology, Hepatology and Nutrition Service, Paediatric Medicine, KK Women's and Children's Hospital, Singapore, Singapore.
- Tunku Abdul Rahman University, Kampar, Perak, Malaysia.
ORCID-Profile: James Guoxian Huang
Zitieren
APA
Huang, J. G., Chew, K. S., Logarajah, V., Lee, W. S., & Aw, M. M. (2025). Phenotypic Differences and Clinical Outcomes of South Asian Children With IBD: A Singapore–Malaysia Study From the Asian PIBD Registry Network. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/jgh.17020
Vancouver
Huang JG, Chew KS, Logarajah V, Lee WS, Aw MM. Phenotypic Differences and Clinical Outcomes of South Asian Children With IBD: A Singapore–Malaysia Study From the Asian PIBD Registry Network. Journal of Gastroenterology and Hepatology. 2025. doi:10.1111/jgh.17020
BibTeX
@article{Huang2025,
author = {Huang, James Guoxian and Chew, Kee Seang and Logarajah, Veena and Lee, Way Seah and Aw, Marion Margaret},
title = {Phenotypic Differences and Clinical Outcomes of South Asian Children With IBD: A Singapore–Malaysia Study From the Asian PIBD Registry Network},
journal = {Journal of Gastroenterology and Hepatology},
year = {2025},
doi = {10.1111/jgh.17020}
}
EUVIMED